Changing the Landscape of Screening: AI-Powered ASMS Ligand Identification
Join Evotec experts Ghislaine Marchand and Benedikt Bauer to explore how AI/ML integration with ASMS accelerates hit identification, reduces costs, and reshapes early-stage drug discovery.